These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

344 related articles for article (PubMed ID: 25139488)

  • 1. What are the pharmacotherapy options for treating prediabetes?
    Daniele G; Abdul-Ghani M; DeFronzo RA
    Expert Opin Pharmacother; 2014 Oct; 15(14):2003-18. PubMed ID: 25139488
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preservation of β-cell function: the key to diabetes prevention.
    DeFronzo RA; Abdul-Ghani MA
    J Clin Endocrinol Metab; 2011 Aug; 96(8):2354-66. PubMed ID: 21697254
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Successful treatment of prediabetes in clinical practice: targeting insulin resistance and β-cell dysfunction.
    Armato J; DeFronzo RA; Abdul-Ghani M; Ruby R
    Endocr Pract; 2012; 18(3):342-50. PubMed ID: 22068250
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacological strategies for preventing type 2 diabetes in patients with impaired glucose tolerance.
    Smith-Marsh D
    Drugs Today (Barc); 2013 Aug; 49(8):499-507. PubMed ID: 23977667
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Drug therapy in prediabetes.
    Mukhopadhyay P; Chowdhury S
    J Indian Med Assoc; 2005 Nov; 103(11):603-5, 608. PubMed ID: 16570765
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A refined-JinQi-JiangTang tablet ameliorates prediabetes by reducing insulin resistance and improving beta cell function in mice.
    Gao LH; Liu Q; Liu SN; Chen ZY; Li CN; Lei L; Sun SJ; Li LY; Liu JL; Shen ZF
    J Ethnopharmacol; 2014; 151(1):675-85. PubMed ID: 24286962
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prediabetes: how pathophysiology drives potential intervention on a subclinical disease with feared clinical consequences.
    DI Giuseppe G; Ciccarelli G; Cefalo CM; Cinti F; Moffa S; Impronta F; Capece U; Pontecorvi A; Giaccari A; Mezza T
    Minerva Endocrinol (Torino); 2021 Sep; 46(3):272-292. PubMed ID: 34218657
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impaired glucose tolerance and impaired fasting glucose--a review of diagnosis, clinical implications and management.
    Petersen JL; McGuire DK
    Diab Vasc Dis Res; 2005 Feb; 2(1):9-15. PubMed ID: 16305067
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification and treatment of prediabetes to prevent progression to type 2 diabetes.
    Fonseca VA
    Clin Cornerstone; 2008; 9(2):51-9; discussion 60-1. PubMed ID: 19410162
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reflecting on type 2 diabetes prevention: more questions than answers!
    Rosenstock J
    Diabetes Obes Metab; 2007 Sep; 9 Suppl 1():3-11. PubMed ID: 17877541
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacotherapeutic options for prediabetes.
    Rendell M
    Expert Opin Pharmacother; 2021 Jan; 22(1):45-54. PubMed ID: 32892663
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of Insulin Resistance and β-Cell Dysfunction Between the Young and the Elderly in Normal Glucose Tolerance and Prediabetes Population: A Prospective Study.
    Chen G; Shi L; Cai L; Lin W; Huang H; Liang J; Li L; Lin L; Tang K; Chen L; Lu J; Bi Y; Wang W; Ning G; Wen J
    Horm Metab Res; 2017 Feb; 49(2):135-141. PubMed ID: 27459384
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Steps toward the primary prevention of type II diabetes mellitus. Various epidemiological considerations].
    Flórez H
    Invest Clin; 1997 Mar; 38(1):39-52. PubMed ID: 9235072
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of transoral gastroplasty on glucose homeostasis in obese subjects.
    Leccesi L; Panunzi S; De Gaetano A; Familiari P; Iaconelli A; Guidone C; Mazzarella A; Costamagna G; Mingrone G
    J Clin Endocrinol Metab; 2013 May; 98(5):1901-10. PubMed ID: 23543657
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessing progression to impaired glucose tolerance and type 2 diabetes mellitus.
    Guerrero-Romero F; Rodríguez-Morán M
    Eur J Clin Invest; 2006 Nov; 36(11):796-802. PubMed ID: 17032347
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Liraglutide prevents diabetes progression in prediabetic OLETF rats.
    Guo N; Sun J; Chen H; Zhang H; Zhang Z; Cai D
    Endocr J; 2013; 60(1):15-28. PubMed ID: 22986487
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Choice of early treatment regimen and impact on β-cell preservation in type 2 diabetes.
    Mudaliar S
    Int J Clin Pract; 2013 Sep; 67(9):876-87. PubMed ID: 23952467
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Progress in the prevention of type 2 diabetes].
    Schernthaner G
    Wien Klin Wochenschr; 2003 Nov; 115(21-22):745-57. PubMed ID: 14743578
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of prediabetes.
    Kanat M; DeFronzo RA; Abdul-Ghani MA
    World J Diabetes; 2015 Sep; 6(12):1207-22. PubMed ID: 26464759
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification and treatment of prediabetes to prevent progression to type 2 diabetes.
    Fonseca VA
    Clin Cornerstone; 2007; 8(2):10-8; discussion 19-20. PubMed ID: 18357952
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.